z-logo
open-access-imgOpen Access
Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema
Author(s) -
Arshad M. Khanani,
Sunil Patel,
Víctor H. González,
Suk J. Moon,
Glenn J. Jaffe,
John A. Wells,
Petra Kozma,
Pravin U. Dugel,
Raj K. Maturi
Publication year - 2021
Publication title -
ophthalmology science
Language(s) - English
Resource type - Journals
ISSN - 2666-9145
DOI - 10.1016/j.xops.2021.100040
Subject(s) - medicine , adverse effect , incidence (geometry) , edema , diabetic macular edema , visual acuity , fluorescein angiography , ophthalmology , surgery , diabetes mellitus , diabetic retinopathy , endocrinology , optics , physics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom